PATENT CLAIM ANALYSIS

Application Number: 16056393
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID N0:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID N0:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.

Claim (Index 18):
The method of  claim 17 , wherein the miRNA comprising the seed region sequence UCACAGU is miR_27a.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.84615
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13376304', '14433150', '13933526', '13511181', '12593066']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7792349788292818
- 35 USC 102 Novelty (BERT): 0.5544992355582463
- Combined Prediction Score: 0.7567614045021783
- Mean Citation Score: 331.2118940000001
- Max Citation Score: 454.79315
- Similarity Product: 305.3159758923382

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test